SwissPrEPared

Switzerland
|
2019-2022
  • Adults
  • Elderly
  • People at high risk of STIs
  • PrEP users
  • Hospital wide
  • Community
  • Primary care
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Syphilis
  • Sexually transmitted infection
  • Pharmacological intervention
  • PrEP-bSTI

DanPrEPD

Denmark
|
2022-2022
  • Adults
  • Elderly
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Syphilis
  • Sexually transmitted infection
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

SeVIHPrEP

Spain
|
2020-2030
  • Adults
  • Elderly
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Mycoplasma genitalium
  • Hepatitis
  • HIV
  • Treponema pallidum
  • Sexually transmitted infection
  • Anal-rectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV

Bellmann-Strobl

Germany
|
2023-2025
  • Adults
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • vasodilator
  • Vericiguat

PROLIFIC

Sweden
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

PYCNOVID

Switzerland
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Pycnogenol

THALASSA

Spain
|
2025-2026
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Plitidepsin
  • Antineoplastic agent

COVMENT

Poland
|
2023-2027
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Anti-depressant
  • Tianeptine

Paraskevis

Greece
|
2022-2022
  • Elderly
  • Fragile population
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Pinchera

Italy
|
2023-2023
  • Adults
  • Elderly
  • Fragile population
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tixagevimab/Cilgavimab

Orth

Germany
|
2022-2023
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Palčić Marija

Croatia
|
2021-2022
  • Adults
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tocilizumab